DECA Intercity Ireland Trip

Description

The Diversity Ethnic Chamber Alliance (DECA comprised of the Austin LGBT, Greater Austin Hispanic, Greater Austin Asian, and Greater Austin Black Chambers of Commerce) is hosting an Intercity Business Trip to Ireland on March 24th-27th of 2024! Attendance will be capped at 20 people.

The individual conference registration ($1,799) includes:

• Full 3 day conference pass
• 3 night hotel stay
• 3 breakfast conference sessions
• 3 lunch conference sessions
• 1 Group Dinner/Distillery Tour
• hospitality suite
• ground transportation to the conference sessions
• $200 Delta voucher for the first 10 registrants

BOOK YOUR FLIGHT and arrive or before March 24th! (your hotel stay will begin on the 24th) The conference will begin on March 25th. Room prices are based on double occupancy.

Sessions:

• Doing business in/with Ireland: Economic Development Overview
• Why Ireland? Reshoring in a global economy and transatlantic ties
• Environmental, Social and Governance
• Transportation, Growth, and Regionalism - Future of work in Ireland
• Legal immigration, citizenship, outlook doing business with EU
• Tax and banking laws
• Tech, People and Process: The new work environment
• Diversity equity and Inclusion in the Irish economy
• Workforce and Talent

The Intercity hotel we have chosen is an urban oasis in the heart of Dublin. Just steps away from Grafton Street, hotel visitors can unwind stroll through the Iveagh Gardens or the nearby St. Stephen’s Green. Situated on Harcourt Street guests can avail of the nearby bustling nightlife or shopping. Europe’s first sustainable hotel!

Conference locations include Dell, Deloitte, Indeed, and RSM. *locations are subject to change due to availability.

Attendees will meet local civic and business leaders, learn about the Irish economy, workforce, transportation, immigration, taxation and more to help you decide if you are ready to do business with or even in Ireland. There are hundreds of US businesses in Ireland. In fact, Ireland is home to 9 of the top 10 US technology companies, 9 of the top 10 pharmaceutical companies, and 14 of the top 15 MedTech companies.